Product Description
The global balloon valvuloplasty market was valued at $145 million in 2025. This is expected to increase over the forecast period at a CAGR of 4.9% to reach $202.9million.
The full report suite on the global market for balloon valvuloplasty (BV) includes aortic, mitral and pulmonary BV devices.
The report includes data for 65 countries across 7 different regions which include North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Balloon Valvuloplasty Market Trends
Balloon valvuloplasty (BV) devices are widely used during transcatheter aortic valve replacement (TAVR) procedures to dilate the native aortic valve and facilitate device delivery and expansion, particularly in cases requiring predilatation or post-dilatation. Their use has traditionally been more common with balloon-expandable TAVR systems, where controlled valve preparation can improve procedural accuracy. However, the increasing adoption of self-expanding TAVR devices and direct-implant strategies has reduced the need for routine balloon predilatation in a subset of procedures, which may limit the pace of expansion of the overall BV device market.
Balloon Valvuloplasty Market Share Insights
- Becton Dickinson was the leading competitor in the global BV market. The company produces the TRUE® Flow and TRUE® DILATION and Vida® BAV for aortic BV. For pulmonary BV procedures, the company offers the Vida™ PTV dilation catheter. Becton Dickinson is expected to maintain its leading share for the coming years.
- Braun was the second-leading competitor in the BV market in 2025. The company offers a range of balloon catheters for pulmonary, aortic and percutaneous angioplasty procedures. B. Braun’s product portfolio includes the line of Tyshak® catheters. While B. Braun has an established line with a global presence, smaller local companies are rising in popularity. This will be reflected in a decline in market share over the coming years for the company.
- Toray held a notable share of the balloon valvuloplasty (BV) market in 2025, supported by its established INOUE™ balloon platform, which remains the only device indicated for mitral valve valvuloplasty in North America. The company further strengthened its portfolio with the launch of the INOUE BALLOON A in September 2024, a dedicated balloon designed specifically for aortic balloon valvuloplasty procedures, aimed at improving dilation performance and procedural reliability in the treatment of aortic valve stenosis. With a strong presence in select regions and rising clinical adoption, Toray is expected to continue expanding its market share over the coming years.
Balloon Valvuloplasty Market Segmentation Summary
- Balloon Valvuloplasty Market – Further Segmented Into:
- Device Type: Aortic, Mitral, Pulmonary.
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
